WELL Health Technologies Corp

Directions Website

WELL Health Technologies Corp WELL Health Technologies Corp. is an EMR service provider & operator of healthcare clinics in Canada

WELL is pleased to announce its participation at the upcoming Cantech Investment Conference on Thursday, October 8, 2026...
10/02/2026

WELL is pleased to announce its participation at the upcoming Cantech Investment Conference on Thursday, October 8, 2026, at the Arcadian Loft in Toronto, Ontario.

WELL will be represented at the conference by Hamed Shahbazi, Chief Executive Officer, who will be delivering the Company’s investor presentation, and Chief Operating Officer, Derek Clark, who will be participating in scheduled 1-on-1 meetings with investors at the conference.

For more info on the conference visit https://www.cantechletter.com/conference/.

WELL is pleased to announce that, WELLSTAR has received conditional approval from the TSX Venture Exchange as a Tier 1 ...
09/28/2026

WELL is pleased to announce that, WELLSTAR has received conditional approval from the TSX Venture Exchange as a Tier 1 issuer, subject to satisfaction of the TSXV’s customary listing conditions, and is expected to commence trading on or around October 1, 2026, under the ticker symbol “WSTR”.

Read more: https://ow.ly/Gj2350ZSfmp

WELL is pleased to announce the launch of WELL Research, WELL’s consolidated clinical research brand. WELL Research offe...
09/22/2026

WELL is pleased to announce the launch of WELL Research, WELL’s consolidated clinical research brand.

WELL Research offers the unique combination of full-service contract research organization (CRO) services in early-phase trials, site management organization (SMO) ex*****on at late-stage trial sites, and bioanalytical services across every phase of clinical trials.

Together, these capabilities span the full clinical trial value chain and allow sponsors and providers to enrol the right trial participants quickly and reliably.

WELL Research is supported by four of WELL's differentiated assets:
🔹 Canada's largest outpatient clinic network (275 clinics supporting 5 million+ annual patient visits)
🔹 WELLSTAR's provider network (45,000+ providers)
🔹 The WELLTrust patient consent platform (100,000+ patient consents)
🔹 HEALWELL AI's DARWEN™ platform for feasibility assessment and protocol-participant matching.

Learn more: https://ow.ly/tsM350ZQ8Bp

WELL today announced a planned transition in its finance leadership including the appointment of Evelyn Sutherland as Ch...
09/09/2026

WELL today announced a planned transition in its finance leadership including the appointment of Evelyn Sutherland as Chief Financial Officer, effective September 21, 2026.

Ms. Sutherland has served on the Board of WELL’s subsidiary WELLSTAR Technologies Corp. over the past year, helping guide WELLSTAR through its go-public process, and brings direct knowledge of WELL’s strategy, governance and culture to the role.

Eva Fong, who helped lead WELL’s evolution from an early-stage start-up into one of Canada’s leading healthcare technology companies, will transition from the CFO role and assume a strategic Executive Advisor position with the Company.

Read full press release here: https://ow.ly/KNBQ50ZLf1Q

WELL a digital healthcare company focused on positively impacting health outcomes, and HEALWELL AI Inc., a healthcare ar...
09/08/2026

WELL a digital healthcare company focused on positively impacting health outcomes, and HEALWELL AI Inc., a healthcare artificial intelligence company, are pleased to announce that WELLTRUST™ has surpassed 100,000 patient consents since its launch in February 2026.

📌 HEALWELL’s DARWEN™ AI platform is used to connect WELLTRUST™ patients with life sciences companies, including pharma and biotech trial sponsors and Contract Research Organizations (CROs), by matching trial protocols against the consented patient population.

📌 Patient consents are captured and managed using OceanMD, WELLSTAR’s patient engagement platform, which presents the WELLTRUST™ consent within the digital check-in workflow patients already use and records it directly in the patient’s chart as a structured, revocable record. The 100,000 milestone was reached entirely organically through in-clinic enrollment.

📌 WELL and HEALWELL intend to significantly scale the WELLTRUST™ consented patient population over the coming quarters through expanded EMR connectivity across WELL’s clinic network and the rollout of new digital consent channels, with the ambition of building one of the largest consented, trial-ready patient networks in North America.

Read the full press release here: https://ow.ly/QlzE50ZKGjN

WELL has released its fifth annual Sustainability and Impact Report: Built for This Moment in Healthcare.A few highlight...
08/27/2026

WELL has released its fifth annual Sustainability and Impact Report: Built for This Moment in Healthcare.

A few highlights from 2025:
📌 1.7M+ eReferrals and 300,000 online bookings supported through WELLSTAR’s Ocean platform
📌 Up to 2 hours saved per day for clinics using WELL’s Nexus AI solutions
📌 392 IT assets reused and approximately 2,770 lbs of e-waste recovered
📌 3,100+ volunteer hours contributed through WELL Cares
📌 Multiple WELL entities recognized as Great Place to Work® certified

The report reflects our continued focus on empowering providers, protecting patient data and building a healthy place to work.

🔗 Read the full Sustainability and Impact Report: https://ow.ly/X2I650ZFUwl

WELL redeemed early all of its outstanding 5.50% convertible senior unsecured debentures due December 31, 2026. The Debe...
08/20/2026

WELL redeemed early all of its outstanding 5.50% convertible senior unsecured debentures due December 31, 2026. The Debentures were redeemed by WELL on August 19, 2026 in accordance with the terms of the Debenture trust indenture.

The Debentures were listed on the Toronto Stock Exchange under the symbol WELL.DB and ceased trading at the opening of trading on the Redemption Date and were delisted at the close of trading on the Redemption Date. The aggregate principal amount of the Debentures outstanding was $70,000,000.

Read the full press release here: https://ow.ly/XOyk50ZBU0K

WELL is pleased to announce its interim consolidated financial results for the quarter ended June 30, 2026. 📌 WELL achie...
08/06/2026

WELL is pleased to announce its interim consolidated financial results for the quarter ended June 30, 2026.

📌 WELL achieved quarterly revenues of $400.4 million in Q2-2026, an increase of 12% as compared to Q2-2025, driven by strong growth in the Company’s Canadian Patient Services Business where quarterly revenue increased by 32% to $151.6 million in Q2-2026 as compared to Q2-2025.

📌 During the quarter, WELL closed two highly-accretive acquisitions, the OID Group and UnionMD, expanding the Company’s Canadian Clinics network to 275 clinics as of June 30, 2026, and boosting WELL Canada’s annualized Adjusted EBITDA run-rate to over $100 million, three calendar quarters ahead of schedule.

📌 Subsequent to quarter end, WELL further strengthened its balance sheet with the closing of an inaugural $150 million senior unsecured notes offering and announced the Company’s intention to list WELLSTAR on the TSXV via an RTO transaction, alongside a concurrent $50 million subscription receipts financing that has since been completed.

📌 WELL is increasing its 2026 annual revenue guidance to a range of $1.58 billion to $1.65 billion, from previous guidance of $1.55 billion to $1.65 billion, and is increasing its Adjusted EBITDA guidance to a range of $185 million to $195 million, from previous guidance of $175 million to $185 million.

Read the full press release here: https://ow.ly/rTPH50ZxcsN

WELL is pleased to announce the appointments of Loreto Grimaldi as Chief Legal Officer ("CLO") and Kaytek Przybylski as ...
08/04/2026

WELL is pleased to announce the appointments of Loreto Grimaldi as Chief Legal Officer ("CLO") and Kaytek Przybylski as Chief Digital & Information Officer ("CDIO").

These appointments further strengthen WELL's executive leadership team as the Company continues to scale Canada's largest outpatient healthcare platform powered by software and AI.

Read more: https://ow.ly/V6vT50Zw9k1

WELL is pleased to announce that the Company will release its Fiscal Second Quarter 2026 financial results for the perio...
08/04/2026

WELL is pleased to announce that the Company will release its Fiscal Second Quarter 2026 financial results for the period ended June 30, 2026, after market close on Thursday, August 6, 2026.

The Company will hold a conference call and simultaneous webcast to discuss its results on the same day, at 5:30 PM ET (2:30 PM PT). The call will be hosted by Hamed Shahbazi, Chairman and Chief Executive Officer, and Eva Fong, Chief Financial Officer.

To attend the webcast, visit well.company/events to register.

Address

375 Water Street Suite 550
Vancouver, BC
V6B5C6

Website

Alerts

Be the first to know and let us send you an email when WELL Health Technologies Corp posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Sponsored

Share

Category